Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000728271 | SCV000855824 | uncertain significance | not provided | 2017-07-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001234445 | SCV001407092 | likely benign | Hajdu-Cheney syndrome | 2025-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004639340 | SCV005142249 | uncertain significance | Inborn genetic diseases | 2024-04-04 | criteria provided, single submitter | clinical testing | The c.4973C>T (p.T1658I) alteration is located in exon 27 (coding exon 27) of the NOTCH2 gene. This alteration results from a C to T substitution at nucleotide position 4973, causing the threonine (T) at amino acid position 1658 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003980361 | SCV004787709 | likely benign | NOTCH2-related disorder | 2022-10-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |